TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 8 April 15, 2013
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
UPCOMING MEETINGS & EVENTS
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 8 April 15, 2013
(The next issue will be on May 1, 2013)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________None Submitted for this issue.
UPCOMING MEETINGS & EVENTS
General info on upcoming meetings:
http://tf7.org/meetings.htm
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1VkYcsTfw-jvoaYijs_Rgh2/
Baldini M, Manfredi AA, Maugeri N (2013) Targeting Platelet-Neutrophil Interactions in Giant-Cell Arteritis. Curr Pharm Des.
http://www.ncbi.nlm.nih.gov/pubmed/23565638
Borhany M, Fatima H, Naz A, Patel H, Shamsi T (2012) Pattern of bleeding and response to therapy in Glanzmann thrombasthenia. Haemophilia 18:e423-425.
http://www.ncbi.nlm.nih.gov/pubmed/22970800
Calzada-Contreras A, Moreno-Hernandez M, Castillo-Torres NP, Souto-Rosillo G, Hernandez-Juarez J, Ricardo-Moreno MT, . . . Majluf-Cruz A (2012) [Reference values for the blood coagulation tests in Mexico: usefulness of the pooled plasma from blood donors]. Rev Invest Clin 64:437-443.
http://www.ncbi.nlm.nih.gov/pubmed/23544306
Chambost H, Santagostino E, Laffan M, Kavakli K (2013) Real-world outcomes with recombinant factor VIIa treatment of acute bleeds in haemophilia patients with inhibitors: results from the international ONE registry. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23557542
Chitalia VC, Shivanna S, Martorell J, Balcells M, Bosch I, Kolandaivelu K, Edelman ER (2013) Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor. Circulation 127:365-376.
http://www.ncbi.nlm.nih.gov/pubmed/23269489
Cronin KR, Mangan TP, Carew JA (2012) Upregulation of the coagulation factor VII gene during glucose deprivation is mediated by activating transcription factor 4. PLoS One 7:e40994.
http://www.ncbi.nlm.nih.gov/pubmed/22848420
Di Minno MN, Dolce A, Mariani G (2013) Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency*. Thromb Haemost 109.
http://www.ncbi.nlm.nih.gov/pubmed/23571462
Escobar M, Maahs J, Hellman E, Donkin J, Forsyth A, Hroma N, . . . Shapiro AD (2012) Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centres. Haemophilia 18:971-981.
http://www.ncbi.nlm.nih.gov/pubmed/22776076
Gonzalez F, Kirwan JP, Rote NS, Minium J (2013) Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome. Am J Physiol Endocrinol Metab 304:E375-383.
http://www.ncbi.nlm.nih.gov/pubmed/23249695
Gruppo RA, Kessler CM, Neufeld EJ, Cooper DL (2013) Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital haemophilia and alloantibody inhibitors (CHwI): the Dosing Observational Study in Hemophilia (DOSE). Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23551918
Gutierrez-Alvarez AM, Medina Silva N, Vargas Bazurto MC, Montoya Osorio S (2006) [Treatment of hemorrhagic dengue in the pediatric population: a systematic review]. Rev Cubana Med Trop 58:212-218.
http://www.ncbi.nlm.nih.gov/pubmed/23424789
Han J, Gerstenhaber JA, Lazarovici P, Lelkes PI (2013) Tissue factor activity and ECM-related gene expression in human aortic endothelial cells grown on electrospun biohybrid scaffolds. Biomacromolecules.
http://www.ncbi.nlm.nih.gov/pubmed/23560456
Hatten BW, Bueso A, French LK, Hendrickson RG, Horowitz BZ (2013) Envenomation by the Great Lakes Bush Viper (Atheris nitschei). Clin Toxicol (Phila) 51:114-116.
http://www.ncbi.nlm.nih.gov/pubmed/23327286
Hvas AM, Andreasen JB, Christiansen K, Ravn HB (2013) Ex-vivo response to blood products and haemostatic agents after paediatric cardiac surgery. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/23571685
Jozwik M (2012) The mechanism of thromboembolism in the course of ovarian hyperstimulation syndrome. Med Wieku Rozwoj 16:269-271.
http://www.ncbi.nlm.nih.gov/pubmed/23378404
Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S (2013) Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults. Am J Clin Pathol 139:370-379.
http://www.ncbi.nlm.nih.gov/pubmed/23429374
Kim TO, Park J, Kang MJ, Lee SH, Jee SR, Ryu DY, . . . Yi JM (2013) DNA hypermethylation of a selective gene panel as a risk marker for colon cancer in patients with ulcerative colitis. Int J Mol Med 31:1255-1261.
http://www.ncbi.nlm.nih.gov/pubmed/23546389
Knobe K, Berntorp E (2012) New treatments in hemophilia: insights for the clinician. Ther Adv Hematol 3:165-175.
http://www.ncbi.nlm.nih.gov/pubmed/23556123
Kulkarni AA, Osmond M, Bapir M, Riddell A, Smith C, Lee CA, Kadir RA (2013) The effect of labour on the coagulation system in the term neonate. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23560603
Liu X, Xue Y, Ding T, Sun J (2012) Enhancement of proinflammatory and procoagulant responses to silica particles by monocyte-endothelial cell interactions. Part Fibre Toxicol 9:36.
http://www.ncbi.nlm.nih.gov/pubmed/22985792
Mackman N (2013) Uremic serum and ubiquitylation of tissue factor. Circulation 127:320-321.
http://www.ncbi.nlm.nih.gov/pubmed/23269490
Mitra B, Cameron PA, Parr MJ, Phillips L (2012) Recombinant factor VIIa in trauma patients with the 'triad of death'. Injury 43:1409-1414.
http://www.ncbi.nlm.nih.gov/pubmed/21345431
Nayak RC, Keshava S, Esmon CT, Pendurthi UR, Rao LV (2013) Rab GTPases Regulate Endothelial Cell Protein C Receptor-Mediated Endocytosis and Trafficking of Factor VIIa. PLoS One 8:e59304.
http://www.ncbi.nlm.nih.gov/pubmed/23555015
Parahuleva MS, Kanse S, Holschermann H, Zheleva K, Zandt D, Worsch M, . . . Erdogan A (2013) Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study. J Thromb Thrombolysis.
http://www.ncbi.nlm.nih.gov/pubmed/23575879
Polyanskaya T, Zorenko V, Karpov E, Sampiev M, Mishin G, Vasiliev D (2012) Experience of recombinant activated factor VII usage during surgery in patients with haemophilia with inhibitors. Haemophilia 18:997-1002.
http://www.ncbi.nlm.nih.gov/pubmed/22672066
Rifaioglu EN, Sen BB, Ekiz O (2013) Mean platelet volume and eosinophilia relationship in patients with bullous pemphigoid. Platelets.
http://www.ncbi.nlm.nih.gov/pubmed/23574380
Salaj P, Ovesna P, Penka M, Hedner U (2012) Analyses of recombinant activated factor VII treatments from clinical practice for rapid bleeding and acute pain control in haemophilia patients with inhibitors. Haemophilia 18:e409-411.
http://www.ncbi.nlm.nih.gov/pubmed/22928909
Shimada K, Takedani H, Inoue K, Yamasaki K (2012) Arthroscopic synovectomy of the elbow covered with rFVIIa in a haemophilia B juvenile with inhibitor. Haemophilia 18:e414-416.
http://www.ncbi.nlm.nih.gov/pubmed/22888990
Skretting G, Iversen N, Myklebust CF, Dahm AE, Sandset PM (2012) Overexpression of tissue factor pathway inhibitor in CHO-K1 cells results in increased activation of NF-kappaB and apoptosis mediated by a caspase-3 independent pathway. Mol Biol Rep 39:10089-10096.
http://www.ncbi.nlm.nih.gov/pubmed/22932941
Stavik B, Skretting G, Olstad OK, Sletten M, Dehli Vigeland M, Sandset PM, Iversen N (2012) TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells. PLoS One 7:e47184.
http://www.ncbi.nlm.nih.gov/pubmed/23071754
Summerhayes R (2013) Laboratory methods for the assay of tissue factor pathway inhibitor in human plasma. Methods Mol Biol 992:289-300.
http://www.ncbi.nlm.nih.gov/pubmed/23546722
Yasumoto A, Madoiwa S, Kashiwakura Y, Ishiwata A, Ohmori T, Mizukami H, . . . Mimuro J (2013) Overexpression of factor VII ameliorates bleeding diathesis of factor VIII-deficient mice with inhibitors. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23566532
Young G, Cooper DL, Gut RZ (2012) Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008). Haemophilia 18:990-996.
http://www.ncbi.nlm.nih.gov/pubmed/22631073
Youngwon N, Kim JE, Lim HS, Han KS, Kim HK (2013) Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay. Biomed Res Int 2013:856754.
http://www.ncbi.nlm.nih.gov/pubmed/23555099
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1VkYcsTfw-jvoaYijs_Rgh2/
Baldini M, Manfredi AA, Maugeri N (2013) Targeting Platelet-Neutrophil Interactions in Giant-Cell Arteritis. Curr Pharm Des.
http://www.ncbi.nlm.nih.gov/pubmed/23565638
Borhany M, Fatima H, Naz A, Patel H, Shamsi T (2012) Pattern of bleeding and response to therapy in Glanzmann thrombasthenia. Haemophilia 18:e423-425.
http://www.ncbi.nlm.nih.gov/pubmed/22970800
Calzada-Contreras A, Moreno-Hernandez M, Castillo-Torres NP, Souto-Rosillo G, Hernandez-Juarez J, Ricardo-Moreno MT, . . . Majluf-Cruz A (2012) [Reference values for the blood coagulation tests in Mexico: usefulness of the pooled plasma from blood donors]. Rev Invest Clin 64:437-443.
http://www.ncbi.nlm.nih.gov/pubmed/23544306
Chambost H, Santagostino E, Laffan M, Kavakli K (2013) Real-world outcomes with recombinant factor VIIa treatment of acute bleeds in haemophilia patients with inhibitors: results from the international ONE registry. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23557542
Chitalia VC, Shivanna S, Martorell J, Balcells M, Bosch I, Kolandaivelu K, Edelman ER (2013) Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor. Circulation 127:365-376.
http://www.ncbi.nlm.nih.gov/pubmed/23269489
Cronin KR, Mangan TP, Carew JA (2012) Upregulation of the coagulation factor VII gene during glucose deprivation is mediated by activating transcription factor 4. PLoS One 7:e40994.
http://www.ncbi.nlm.nih.gov/pubmed/22848420
Di Minno MN, Dolce A, Mariani G (2013) Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency*. Thromb Haemost 109.
http://www.ncbi.nlm.nih.gov/pubmed/23571462
Escobar M, Maahs J, Hellman E, Donkin J, Forsyth A, Hroma N, . . . Shapiro AD (2012) Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centres. Haemophilia 18:971-981.
http://www.ncbi.nlm.nih.gov/pubmed/22776076
Gonzalez F, Kirwan JP, Rote NS, Minium J (2013) Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome. Am J Physiol Endocrinol Metab 304:E375-383.
http://www.ncbi.nlm.nih.gov/pubmed/23249695
Gruppo RA, Kessler CM, Neufeld EJ, Cooper DL (2013) Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital haemophilia and alloantibody inhibitors (CHwI): the Dosing Observational Study in Hemophilia (DOSE). Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23551918
Gutierrez-Alvarez AM, Medina Silva N, Vargas Bazurto MC, Montoya Osorio S (2006) [Treatment of hemorrhagic dengue in the pediatric population: a systematic review]. Rev Cubana Med Trop 58:212-218.
http://www.ncbi.nlm.nih.gov/pubmed/23424789
Han J, Gerstenhaber JA, Lazarovici P, Lelkes PI (2013) Tissue factor activity and ECM-related gene expression in human aortic endothelial cells grown on electrospun biohybrid scaffolds. Biomacromolecules.
http://www.ncbi.nlm.nih.gov/pubmed/23560456
Hatten BW, Bueso A, French LK, Hendrickson RG, Horowitz BZ (2013) Envenomation by the Great Lakes Bush Viper (Atheris nitschei). Clin Toxicol (Phila) 51:114-116.
http://www.ncbi.nlm.nih.gov/pubmed/23327286
Hvas AM, Andreasen JB, Christiansen K, Ravn HB (2013) Ex-vivo response to blood products and haemostatic agents after paediatric cardiac surgery. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/23571685
Jozwik M (2012) The mechanism of thromboembolism in the course of ovarian hyperstimulation syndrome. Med Wieku Rozwoj 16:269-271.
http://www.ncbi.nlm.nih.gov/pubmed/23378404
Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S (2013) Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults. Am J Clin Pathol 139:370-379.
http://www.ncbi.nlm.nih.gov/pubmed/23429374
Kim TO, Park J, Kang MJ, Lee SH, Jee SR, Ryu DY, . . . Yi JM (2013) DNA hypermethylation of a selective gene panel as a risk marker for colon cancer in patients with ulcerative colitis. Int J Mol Med 31:1255-1261.
http://www.ncbi.nlm.nih.gov/pubmed/23546389
Knobe K, Berntorp E (2012) New treatments in hemophilia: insights for the clinician. Ther Adv Hematol 3:165-175.
http://www.ncbi.nlm.nih.gov/pubmed/23556123
Kulkarni AA, Osmond M, Bapir M, Riddell A, Smith C, Lee CA, Kadir RA (2013) The effect of labour on the coagulation system in the term neonate. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23560603
Liu X, Xue Y, Ding T, Sun J (2012) Enhancement of proinflammatory and procoagulant responses to silica particles by monocyte-endothelial cell interactions. Part Fibre Toxicol 9:36.
http://www.ncbi.nlm.nih.gov/pubmed/22985792
Mackman N (2013) Uremic serum and ubiquitylation of tissue factor. Circulation 127:320-321.
http://www.ncbi.nlm.nih.gov/pubmed/23269490
Mitra B, Cameron PA, Parr MJ, Phillips L (2012) Recombinant factor VIIa in trauma patients with the 'triad of death'. Injury 43:1409-1414.
http://www.ncbi.nlm.nih.gov/pubmed/21345431
Nayak RC, Keshava S, Esmon CT, Pendurthi UR, Rao LV (2013) Rab GTPases Regulate Endothelial Cell Protein C Receptor-Mediated Endocytosis and Trafficking of Factor VIIa. PLoS One 8:e59304.
http://www.ncbi.nlm.nih.gov/pubmed/23555015
Parahuleva MS, Kanse S, Holschermann H, Zheleva K, Zandt D, Worsch M, . . . Erdogan A (2013) Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study. J Thromb Thrombolysis.
http://www.ncbi.nlm.nih.gov/pubmed/23575879
Polyanskaya T, Zorenko V, Karpov E, Sampiev M, Mishin G, Vasiliev D (2012) Experience of recombinant activated factor VII usage during surgery in patients with haemophilia with inhibitors. Haemophilia 18:997-1002.
http://www.ncbi.nlm.nih.gov/pubmed/22672066
Rifaioglu EN, Sen BB, Ekiz O (2013) Mean platelet volume and eosinophilia relationship in patients with bullous pemphigoid. Platelets.
http://www.ncbi.nlm.nih.gov/pubmed/23574380
Salaj P, Ovesna P, Penka M, Hedner U (2012) Analyses of recombinant activated factor VII treatments from clinical practice for rapid bleeding and acute pain control in haemophilia patients with inhibitors. Haemophilia 18:e409-411.
http://www.ncbi.nlm.nih.gov/pubmed/22928909
Shimada K, Takedani H, Inoue K, Yamasaki K (2012) Arthroscopic synovectomy of the elbow covered with rFVIIa in a haemophilia B juvenile with inhibitor. Haemophilia 18:e414-416.
http://www.ncbi.nlm.nih.gov/pubmed/22888990
Skretting G, Iversen N, Myklebust CF, Dahm AE, Sandset PM (2012) Overexpression of tissue factor pathway inhibitor in CHO-K1 cells results in increased activation of NF-kappaB and apoptosis mediated by a caspase-3 independent pathway. Mol Biol Rep 39:10089-10096.
http://www.ncbi.nlm.nih.gov/pubmed/22932941
Stavik B, Skretting G, Olstad OK, Sletten M, Dehli Vigeland M, Sandset PM, Iversen N (2012) TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells. PLoS One 7:e47184.
http://www.ncbi.nlm.nih.gov/pubmed/23071754
Summerhayes R (2013) Laboratory methods for the assay of tissue factor pathway inhibitor in human plasma. Methods Mol Biol 992:289-300.
http://www.ncbi.nlm.nih.gov/pubmed/23546722
Yasumoto A, Madoiwa S, Kashiwakura Y, Ishiwata A, Ohmori T, Mizukami H, . . . Mimuro J (2013) Overexpression of factor VII ameliorates bleeding diathesis of factor VIII-deficient mice with inhibitors. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23566532
Young G, Cooper DL, Gut RZ (2012) Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008). Haemophilia 18:990-996.
http://www.ncbi.nlm.nih.gov/pubmed/22631073
Youngwon N, Kim JE, Lim HS, Han KS, Kim HK (2013) Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay. Biomed Res Int 2013:856754.
http://www.ncbi.nlm.nih.gov/pubmed/23555099
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
